Serial No. 115-73: Concerns Over Federal Select Agent Program Oversight of Dangerous Pathogens, Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, November 2, 2017 [open pdf - 3MB]
This is the November 2, 2017 hearing titled "Concerns Over Federal Select Agent Program Oversight of Dangerous Pathogens," held before the House Subcommittee on Oversight and Investigations. From the opening statement of Morgan Griffith: "The Federal Select Agent Program under the joint management of the CDC [Centers for Disease Control and Prevention] and the USDA's Animal and Plant Health Inspection Services was established by legislation enacted in 2002, shortly after the 9/11 attacks and the anthrax mailings. These events supported Congress to conclude that certain dangerous pathogens, such as anthrax, smallpox, and plagues called select agents and toxins required regulation of its possession, use, and transfer. The program oversees 276 registered laboratories and almost 4,000 individuals involved with vital research in the diagnostics, vaccines, and medical countermeasures that save lives, protect American agriculture, and help protect the safety and security of the American people. In 2016, the program conducted 181 inspections of registered laboratories, and was notified of 177 separate incidents involving potential exposures with 998 lab workers monitored but, fortunately, with no illnesses developed." Statements, letters, and materials submitted for the record include those of the following: Mary Denigan-Macauley, Samuel Edwin, and Freeda Isaac.
Serial No. 115-73
U.S. Government Publishing Office: http://www.gpo.gov/